Capital International, Inc. Moderna, Inc. Transaction History

Capital International, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$96.41 - $126.61 $113,956 - $149,653	-1,182 Reduced 10.87%	9,694 $1 Million
Q2 2023 Aug 11, 2023	SELL	$118.5 - $160.53 $490,234 - $664,112	-4,137 Reduced 27.56%	10,876 $1.32 Million
Q1 2023 May 15, 2023	BUY	$135.66 - $197.02 $1.49 Million - $2.17 Million	11,017 Added 275.7%	15,013 $2.31 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $473,046 - $839,319	3,996 New	3,996 $717,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $313,494 - $582,688	-2,479 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $32,969 - $53,802	146 Added 6.26%	2,479 $630,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $86,097 - $187,974	-388 Reduced 14.26%	2,333 $898,000
Q2 2021 Aug 16, 2021	SELL	$129.91 - $234.98 $1.3 Million - $2.35 Million	-10,011 Reduced 78.63%	2,721 $639,000
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $1.39 Million - $2.37 Million	12,732 New	12,732 $1.67 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

Stay updated on Capital International, Inc. with notifications on news.